Status:
COMPLETED
Vitamin D Pilot Study in Patients With Multiple Sclerosis
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Relapsing Remitting Multiple Sclerosis
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Eligibility Criteria
Inclusion
- relapsing remitting MS
Exclusion
- MRI contraindicated
Key Trial Info
Start Date :
February 1 1998
Trial Type :
INTERVENTIONAL
End Date :
June 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01257958
Start Date
February 1 1998
End Date
June 1 2000
Last Update
October 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UW-Madison
Madison, Wisconsin, United States, 53792